[Use of the B19 strain in the prevention of bovine brucellosis in northern Cameroon. Study of effect of the dose on seroconversion rate and duration in female zebu]

Rev Elev Med Vet Pays Trop. 1995;48(1):37-40.
[Article in French]

Abstract

Four herds of zebus from northern Cameroon totalling 136 animals were vaccinated subcutaneously with the following doses of Brucella abortus strain 19: 5 x 10(9) colony-forming units (CFU), 10(9) CFU, 5 x 10(8) CFU and 10(7) CFU. Twenty-eight days after vaccination, the following seroconversion rates were observed respectively: 97.4, 96.2 84.2 and 73.3%. Of the 52 animals which could be tested subsequently including 39 over one year old on the vaccination day, only one showed antibodies 6 months after vaccination. The cost price of the strain 19 vaccine produced at the Boklé National Veterinary Laboratory was estimated to be 65 F CFA at the 10(9) CFU dose and 1,740 F CFA at the 5 x 10(10) CFU dose usually recommended. The use of the Buck 19 strain in the medical prophylaxis of bovine brucellosis in northern Cameroon is discussed.

MeSH terms

  • Animals
  • Antibodies, Bacterial / analysis
  • Brucella Vaccine / administration & dosage*
  • Brucella abortus / classification
  • Brucella abortus / immunology*
  • Brucellosis, Bovine / prevention & control*
  • Cameroon
  • Cattle
  • Dose-Response Relationship, Drug
  • Female
  • Time Factors

Substances

  • Antibodies, Bacterial
  • Brucella Vaccine